Related references
Note: Only part of the references are listed.15-Hydroxyprostaglandin Dehydrogenase is Downregulated and Exhibits Tumor Suppressor Activity in Gastric Cancer
Ho June Song et al.
CANCER INVESTIGATION (2011)
Macrophages programmed by apoptotic cells promote angiogenesis via prostaglandin E2
Kerstin Brecht et al.
FASEB JOURNAL (2011)
Loss of 15-Hydroxyprostaglandin Dehydrogenase Expression Contributes to Bladder Cancer Progression
Stephanie Tseng-Rogenski et al.
AMERICAN JOURNAL OF PATHOLOGY (2010)
UV Radiation Inhibits 15-Hydroxyprostaglandin Dehydrogenase Levels in Human Skin: Evidence of Transcriptional Suppression
Benjamin L. Judson et al.
CANCER PREVENTION RESEARCH (2010)
Reduction of 15-hydroxyprostaglandin dehydrogenase expression is an independent predictor of poor survival associated with enhanced cell proliferation in gastric adenocarcinoma
Hiroshi Tatsuwaki et al.
CANCER SCIENCE (2010)
Polymorphisms in fatty acid metabolism-related genes are associated with colorectal cancer risk
Birgit Hoeft et al.
CARCINOGENESIS (2010)
Interleukin-4 up-regulates 15-hydroxyprostaglandin dehydrogenase (15-PGDH) in human lung cancer cells
Xiuling Chi et al.
EXPERIMENTAL CELL RESEARCH (2010)
Expression of eicosanoid biosynthetic and catabolic enzymes in peritoneal endometriosis
J-C. Lousse et al.
HUMAN REPRODUCTION (2010)
Tumor-mediated induction of myeloid-derived suppressor cells and M2-polarized macrophages by altering intracellular PGE2 catabolism in myeloid cells
Evgeniy Eruslanov et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2010)
Expression of vitamin D receptor (VDR), cyclooxygenase-2 (COX-2) and 15-hydroxyprostaglandin dehydrogenase (15-PGDH) in benign and malignant ovarian tissue and 25-hydroxycholecalciferol (25(OH2)D3) and prostaglandin E2 (PGE2) serum level in ovarian cancer patients
Marc Thill et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2010)
Vitamin D and breast cancer: Inhibition of estrogen synthesis and signaling
Aruna V. Krishnan et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2010)
Restoration of leukotriene B4-12-hydroxydehydrogenase/15-oxo-prostaglandin 13-reductase (LTBDH/PGR) expression inhibits lung cancer growth in vitro and in vivo
Yuhua Zhao et al.
LUNG CANCER (2010)
Loss of 15-Hydroxyprostaglandin Dehydrogenase Increases Prostaglandin E2 in Pancreatic Tumors
Hung Pham et al.
PANCREAS (2010)
15-Hydroxyprostaglandin dehydrogenase (15-PGDH) is up-regulated by flurbiprofen and other non-steroidal anti-inflammatory drugs in human colon cancer HT29 cells
Xiuling Chi et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2009)
Mechanisms of Cyclooxygenase-2 Inhibition and Cardiovascular Side Effects-The Plot Thickens
Lawrence J. Marnett
CANCER PREVENTION RESEARCH (2009)
15-Hydroxyprostaglandin Dehydrogenase Is Down-regulated in Gastric Cancer
Alexandra Thiel et al.
CLINICAL CANCER RESEARCH (2009)
Altered Expression of 15-Hydroxyprostaglandin Dehydrogenase in Tumor-Infiltrated CD11b Myeloid Cells: A Mechanism for Immune Evasion in Cancer
Evgeniy Eruslanov et al.
JOURNAL OF IMMUNOLOGY (2009)
Experimental cancer therapy using restoration of NAD+-linked 15-hydroxyprostaglandin dehydrogenase expression
Lyudmila N. Kaliberova et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Omega-3 polyunsaturated fatty acids inhibit hepatocellular carcinoma cell growth through blocking β-catenin and cyclooxygenase-2
Kyu Lim et al.
MOLECULAR CANCER THERAPEUTICS (2009)
15-Hydroxyprostaglandin dehydrogenase inactivation as a mechanism of resistance to celecoxib chemoprevention of colon tumors
Min Yan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Inhibition of prostaglandin synthesis and actions contributes to the beneficial effects of calcitriol in prostate cancer
Aruna V. Krishnan et al.
DERMATO-ENDOCRINOLOGY (2009)
Suppression of Invasive Properties of Colorectal Carcinoma SW480 Cells by 15-Hydroxyprostaglandin Dehydrogenase Gene
Meining Li et al.
CANCER INVESTIGATION (2008)
Colorectal Neoplasia Goes with the Flow: Prostaglandin Transport and Termination
Sanford D. Markowitz
CANCER PREVENTION RESEARCH (2008)
Focusing Downstream in Lung Cancer Prevention: 15-Hydroxyprostaglandin Dehydrogenase
Steven M. Dubinett et al.
CANCER PREVENTION RESEARCH (2008)
NAD+-Dependent 15-Hydroxyprostaglandin Dehydrogenase Regulates Levels of Bioactive Lipids in Non-Small Cell Lung Cancer
Duncan Hughes et al.
CANCER PREVENTION RESEARCH (2008)
Regulation of Prostaglandin Transporters in Colorectal Neoplasia
Vijaykumar R. Holla et al.
CANCER PREVENTION RESEARCH (2008)
Repression of 15-Hydroxyprostaglandin Dehydrogenase Involves Histone Deacetylase 2 and Snail in Colorectal Cancer
Michael G. Backlund et al.
CANCER RESEARCH (2008)
Nonsteroidal anti-inflammatory drugs suppress glioma via 15-hydroxyprostaglandin dehydrogenase
Naoki Wakimoto et al.
CANCER RESEARCH (2008)
15-hydroxyprostaglandin dehydrogenase is a target of hepatocyte nuclear factor 3β and a tumor suppressor in lung cancer
Guosheng Huang et al.
CANCER RESEARCH (2008)
Silibinin inhibits colorectal cancer growth by inhibiting tumor cell proliferation and angiogenesis
Rana P. Singh et al.
CANCER RESEARCH (2008)
Cyclooxygenase-2-derived prostaglandin E2 activates β-catenin in human cholangiocarcinoma cells:: Evidence for inhibition of these signaling pathways by ω3 polyunsaturated fatty acids
Kyu Lim et al.
CANCER RESEARCH (2008)
Expression of 15-PGDH is downregulated by COX-2 in gastric cancer
Zhenxiong Liu et al.
CARCINOGENESIS (2008)
15-Prostaglandin Dehydrogenase Expression Alone or in Combination with ACSM1 Defines a Subgroup of the Apocrine Molecular Subtype of Breast Carcinoma
Julio E. Celis et al.
MOLECULAR & CELLULAR PROTEOMICS (2008)
Mutations in 15-hydroxyprostaglandin dehydrogenase cause primary hypertrophic osteoarthropathy
Sandeep Uppal et al.
NATURE GENETICS (2008)
The cyclooxygenase-2-mediated prostaglandin signaling is causally related to epithelial carcinogenesis
Karin Mueller-Decker et al.
MOLECULAR CARCINOGENESIS (2007)
Inhibition of epidermal growth factor receptor signaling elevates 15-hydroxyprostaglandin dehydrogenase in non-small-cell lung cancer
Li Yang et al.
CANCER RESEARCH (2007)
N6-isopentenyladenosine: A potential therapeutic agent for a variety of epithelial cancers
Monica Spinola et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Pioglitazone and rosiglitazone decrease prostaglandin E2 in non-small-cell lung cancer cells by up-regulating 15-hydroxyprostaglandin dehydrogenase
Saswati Hazra et al.
MOLECULAR PHARMACOLOGY (2007)
Expression of 15-hydroxyprostaglandin dehydrogenase, a COX-2 antagonist and tumour suppressor, is not altered in gastric carcinomas
Nam Jin Yoo et al.
PATHOLOGY (2007)
Reciprocal regulation of cyclooxygenase-2 and 15-hydroxyprostaglandin dehydrogenase expression in A549 human lung adenocarcinoma cells
Min Tong et al.
CARCINOGENESIS (2006)
Histone deacetylase inhibitors and transforming growth factor-β induce 15-hydroxyprostaglandin dehydrogenase expression in human lung adenocarcinoma cells
Min Tong et al.
BIOCHEMICAL PHARMACOLOGY (2006)
15-Hydroxyprostaglandin dehydrogenase is an in vivo suppressor of colon tumorigenesis
Seung-Jae Myung et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
15-hydroxyprostaglandin dehydrogenase is a tumor suppressor of human breast cancer
Ido Wolf et al.
CANCER RESEARCH (2006)
Repression of prostaglandin dehydrogenase by epidermal growth factor and snail increases prostaglandin E2 and promotes cancer progression
Jason R. Mann et al.
CANCER RESEARCH (2006)
IL-4 regulates COX-2 and PGE2production in human non-small cell lung cancer
XY Cui et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
NAD(+)-linked 15-hydroxyprostaglandin dehydrogenase: Structure and biological functions
HH Tai et al.
CURRENT PHARMACEUTICAL DESIGN (2006)
Novel molecular signaling and classification of human clinically nonfunctional pituitary adenomas identified by gene expression profiling and proteomic analyses
CS Moreno et al.
CANCER RESEARCH (2005)
Functional epigenomics identifies genes frequently silenced in prostate cancer
D Lodygin et al.
CANCER RESEARCH (2005)
15-Hydroxyprostaglandin dehydrogenase can be induced by dexamethasone and other glucocorticoids at the therapeutic level in A549 human lung adenocarcinoma cells
M Tong et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2005)
15-hydroxyprostaglandin dehydrogenase is down-regulated in colorectal cancer
MG Backlund et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
NAD(+)-linked 15-hydroxyprostaglandin dehydrogenase (15-PGDH) behaves as a tumor suppressor in lung cancer
YF Ding et al.
CARCINOGENESIS (2005)
The two-step model of prostaglandin signal termination: In vitro reconstitution with the prostaglandin transporter and prostaglandin 15 dehydrogenase
T Nomura et al.
MOLECULAR PHARMACOLOGY (2004)
15-hydroxyprostagland in dehydrogenase, a COX-2 oncogene antagonist, is a TGF-β-induced suppressor of human gastrointestinal cancers
M Yan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Cytokeratin 20, AN43, PGDH, and COX-2 expression in transitional and squamous cell carcinoma of the bladder
JR Gee et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2003)
Indomethacin, a cox inhibitor, enhances 15-PGDH and decreases human tumoral C cells proliferation
M Frenkian et al.
PROSTAGLANDINS & OTHER LIPID MEDIATORS (2001)
Indomethacin increases 15-PGDH mRNA expression in HL60 cells differentiated by PMA
M Frenkian et al.
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS (2001)
The human NAD+-dependent 15-hydroxyprostaglandin dehydrogenase gene promoter is controlled by Ets and activating protein-1 transcription factors and progesterone
KJ Greenland et al.
ENDOCRINOLOGY (2000)
Share Paper
